Vorinostat
CAS: 149647-78-9
Ref. 3D-FH15949
1g | 318.00 € | ||
2g | 468.00 € | ||
5g | 771.00 € | ||
1kg | 12,552.00 € | ||
2kg | 21,162.00 € |
Product Information
- N-Hydroxy-N'-phenyl-octanediamide Suberoylanilide hydroxamic acid SAHA
- Ccris 8456
- M344
- N-Hydroxy-N'-phenyloctanediamide
- N-Hyrdroxy-N'-phenyloctanediamide
- N<sup>1</sup>-Hydroxy-N<sup>8</sup>-phenyloctanediamide
- Octanediamide, N-hydroxy-N'-phenyl-
- Octanediamide, N<sup>1</sup>-hydroxy-N<sup>8</sup>-phenyl-
- SAHA cpd
- Suberanilohydroxamic acid
- See more synonyms
- Suberoyl anilide bishydroxamide
- Suberoylanilide Hydroxamic Acid
- Unii-58Ifb293Ji
- Vorinostat [USAN]
- Wt 171
- Zolinza
- Octanediamide, N1-hydroxy-N8-phenyl-
- SAHA
- N1-Hydroxy-N8-phenyloctanediamide
Vorinostat is a histone deacetylase inhibitor which interferes with gene transcription regulatory mechanisms. It targets histones and non-histone proteins within transcription factor complexes involved in regulation of cell proliferation (p53), protein stability (Hsp90), apoptosis (Bcl-2 family), cell motility (α-tublin), and angiogenesis (HIF-1α). Vorinostat affects epigenetic regulation in various cancers and has been used in clinical trials as anticancer drug.
Chemical properties
Technical inquiry about: 3D-FH15949 Vorinostat
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.